Clinical Trials Browser

Phase 2/3 × Adrenal Gland Neoplasms × Clear all

NCT06100367 2025-12-02

11C-Metomidate PET/CT for Endocrine Hypertension and Characterisation of Adrenal Tumours

Phase 2/3 Active not recruiting

Adrenal Gland Neoplasms, Hyperaldosteronism, Neoplasm Metastasis

NCT00997594 2015-04-28

Changes in Adrenal Hormones During Adrenal Radiofrequency Ablation

Phase 2/3 Completed

18 enrolled 6 charts

Adrenal Gland Neoplasms